Scroll To Top

FDA approves
nausea drug for cancer patients

FDA approves
nausea drug for cancer patients

The Food and Drug Administration on Wednesday approved Merck's antinausea medication Emend for use in conjunction with other antinausea drugs to treat cancer patients receiving chemotherapy. Emend, made by Merck, was shown in a study of breast cancer patients to significantly reduce the chances for nausea and vomiting when added to a regimen of already-approved antinausea drugs. Many of the women studied reported a complete lack of nausea when taking regimens including Emend. (

Advocate Magazine - KehlaniAdvocate Channel Promotion

From our Sponsors

Most Popular

Be sure to follow Advocate on your favorite social platforms!


Want more news, top stories, and videos? Check out the all NEW Advocate Channel!
Your 24/7 streaming source for equality news and lifestyle trends.
Click this link right now:

Latest Stories